Mid-Cap
SoFi Strikes $2 Billion Deal with Fortress Investment to Expand Personal Loan Business
Strategic Partnership Marks a Major Step in Diversifying Revenue Sources SoFi Technologies (SOFI), an online bank with a vision of...
Affirm Holdings Upgraded to Neutral as Lower Interest Rates Brighten Outlook
Reduced Funding Costs and GMV Growth to Bolster the Buy Now, Pay Later Pioneer Shares of Affirm Holdings (AFRM), a...
CATX Showcases Breakthroughs in Radiopharmaceutical Development at Oppenheimer Summit
Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided...
OnKure Positioned for Success with PI3Kα Inhibitor OKI-219 in Breast Cancer
Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in...
Emerging Therapeutic Developments: TYRA, RVMD, IDYA, and More Poised for Key Data Releases
Major trials signal potential advancements in cancer treatment and rare disease therapies Biotech companies are preparing for significant milestones as...
Spirit Airlines Faces Uncertain Future Amid Merger Fallout and Financial Struggles
Debt, Competition, and Engine Issues Continue to Pressure the Carrier Spirit Airlines (SAVE) has endured a turbulent year, losing more...
NIO: A High-Growth Electric Vehicle Stock with Strong Upside Potential
Why Investors Should Consider Adding NIO to Their Portfolio NIO Inc. (NIO), the Chinese electric vehicle (EV) maker, has been...
Ligand Pharmaceuticals: A Diversified Biotech Powerhouse Poised for Growth
With Over 70 Royalty Streams, Ligand’s Unique Business Model Offers Compelling Opportunities for Investors Ligand Pharmaceuticals (LGND) is rapidly emerging...
Larimar Therapeutics Poised for Growth with Nomlabofusp: Target Price Set at $22
FDA START Program and Strong Financials Offer Promising Outlook for Friedreich’s Ataxia Treatment Larimar Therapeutics (LRMR) is making waves in...
Dine Brands Global Set for Strong Rebound: Accelerated Share Repurchase Plan and Strategic Value Initiatives Expected to Drive Growth
Franchised Model, Ongoing Cash Flow, and Refinancing Catalysts Bolster Positive Outlook Dine Brands Global (DIN), the parent company of well-known...
